Phillip LaRussa

1.2k total citations
16 papers, 862 citations indexed

About

Phillip LaRussa is a scholar working on Epidemiology, Virology and Animal Science and Zoology. According to data from OpenAlex, Phillip LaRussa has authored 16 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 6 papers in Virology and 4 papers in Animal Science and Zoology. Recurrent topics in Phillip LaRussa's work include Herpesvirus Infections and Treatments (10 papers), Poxvirus research and outbreaks (4 papers) and Animal Virus Infections Studies (4 papers). Phillip LaRussa is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Poxvirus research and outbreaks (4 papers) and Animal Virus Infections Studies (4 papers). Phillip LaRussa collaborates with scholars based in United States, Cameroon and Puerto Rico. Phillip LaRussa's co-authors include Anne A. Gershon, Kimberly Freudigman, Sharon P. Steinberg, Eugene D. Shapiro, Marietta Vázquez, Sharon Steinberg, A. A. Gershon, Octavian Lungu, Paula W. Annunziato and Susan M. Staugaitis and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.

In The Last Decade

Phillip LaRussa

16 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip LaRussa United States 10 682 228 169 167 159 16 862
Michael Remington United States 16 1.2k 1.8× 216 0.9× 327 1.9× 52 0.3× 119 0.7× 20 1.5k
Patricia Defechereux United States 18 603 0.9× 238 1.0× 415 2.5× 106 0.6× 38 0.2× 32 951
Allan M. Arbeter United States 21 736 1.1× 134 0.6× 150 0.9× 160 1.0× 115 0.7× 39 936
Karen E. Mark United States 13 577 0.8× 160 0.7× 178 1.1× 39 0.2× 39 0.2× 21 798
Alexander J. Ryncarz United States 6 670 1.0× 155 0.7× 196 1.2× 33 0.2× 58 0.4× 8 787
P. A. Brunell United States 15 835 1.2× 155 0.7× 131 0.8× 178 1.1× 144 0.9× 27 938
Takao Nagai Japan 19 717 1.1× 115 0.5× 324 1.9× 150 0.9× 105 0.7× 47 970
Himal Lal Belgium 14 1.3k 1.9× 265 1.2× 215 1.3× 181 1.1× 376 2.4× 23 1.6k
Annedore Tischer Germany 18 857 1.3× 45 0.2× 266 1.6× 40 0.2× 49 0.3× 36 1.0k
S. R. Preblud United States 14 960 1.4× 86 0.4× 328 1.9× 42 0.3× 64 0.4× 18 1.2k

Countries citing papers authored by Phillip LaRussa

Since Specialization
Citations

This map shows the geographic impact of Phillip LaRussa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip LaRussa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip LaRussa more than expected).

Fields of papers citing papers by Phillip LaRussa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip LaRussa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip LaRussa. The network helps show where Phillip LaRussa may publish in the future.

Co-authorship network of co-authors of Phillip LaRussa

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip LaRussa. A scholar is included among the top collaborators of Phillip LaRussa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip LaRussa. Phillip LaRussa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Buregyeya, Esther, Elizeus Rutebemberwa, Phillip LaRussa, et al.. (2017). Comparison of the capacity between public and private health facilities to manage under-five children with febrile illnesses in Uganda. Malaria Journal. 16(1). 183–183. 20 indexed citations
3.
Tseng, Hung Fu, D. Scott Schmid, Rafael Harpaz, et al.. (2014). Herpes Zoster Caused by Vaccine-Strain Varicella Zoster Virus in an Immunocompetent Recipient of Zoster Vaccine. Clinical Infectious Diseases. 58(8). 1125–1128. 39 indexed citations
4.
Rigaud, Mona, William Borkowsky, Petronella Muresan, et al.. (2008). Impaired Immunity to Recall Antigens and Neoantigens in Severely Immunocompromised Children and Adolescents during the First Year of Effective Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 198(8). 1123–1130. 26 indexed citations
5.
Mellins, Claude A., Kathleen Malee, Lynnette Harris, et al.. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 20(8). 958–968. 105 indexed citations
6.
Llorente, Antolin M., Pim Brouwers, Bruce Thompson, et al.. (2006). Effects of Polymorphisms of Chemokine Receptors on Neurodevelopment and the Onset of Encephalopathy in Children with Perinatal HIV-1 Infection. Applied Neuropsychology. 13(3). 180–189. 4 indexed citations
7.
Pepose, Jay S., Todd P. Margolis, Phillip LaRussa, & Deborah Pavan‐Langston. (2003). Ocular complications of smallpox vaccination. American Journal of Ophthalmology. 136(2). 343–352. 37 indexed citations
8.
Levy, Ofer, Jordan S. Orange, Patricia L. Hibberd, et al.. (2003). Disseminated Varicella Infection Due to the Vaccine Strain of Varicella‐Zoster Virus, in a Patient with a Novel Deficiency in Natural Killer T Cells. The Journal of Infectious Diseases. 188(7). 948–953. 126 indexed citations
9.
Vázquez, Marietta, Phillip LaRussa, Anne A. Gershon, et al.. (2001). The Effectiveness of the Varicella Vaccine in Clinical Practice. New England Journal of Medicine. 344(13). 955–960. 265 indexed citations
10.
Gershon, Anne A. & Phillip LaRussa. (1998). VARICELLA VACCINE. The Pediatric Infectious Disease Journal. 17(3). 248–249. 6 indexed citations
11.
Gershon, Anne A., Phillip LaRussa, Sharon Steinberg, et al.. (1996). The Protective Effect of Immunologic Boosting against Zoster: An Analysis in Leukemic Children Who Were Vaccinated against Chickenpox. The Journal of Infectious Diseases. 173(2). 450–453. 88 indexed citations
12.
Lungu, Octavian, Paula W. Annunziato, A. A. Gershon, et al.. (1995). Reactivated and latent varicella-zoster virus in human dorsal root ganglia.. Proceedings of the National Academy of Sciences. 92(24). 10980–10984. 120 indexed citations
13.
LaRussa, Phillip. (1986). DETERMINATION OF IMMUNITY TO VARICELLA-ZOSTER VIRUS BY MEANS OF AN INTRADERMAL SKIN TEST. The Pediatric Infectious Disease Journal. 5(2). 284–284. 1 indexed citations
14.
Borkowsky, William, Phillip H. Klesius, Shelley Gordon, Phillip LaRussa, & H. Sherwood Lawrence. (1985). 959 EFFICACY OF BOVINE LEUKOCYTE DIALYSATES CONTAINING TRANSFER FACTOR (TF) IN THE THERAPY OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS). Pediatric Research. 19(4). 270A–270A. 1 indexed citations
15.
Steinberg, Sharon, et al.. (1985). A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.. PubMed. 61 Suppl 4. 73–8. 17 indexed citations
16.
Gershon, Anne A., Sharon Steinberg, Gennaro Galasso, et al.. (1984). Live attenuated varicella vaccine in children with leukemia in remission.. PubMed. 27(2-3). 77–81. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026